Overview

Urinalysis Market is estimated to value over USD 4.57 billion by 2027 end with a CAGR of over 7.5% during the forecast period 2020 to 2027.

Increased prevalence of targeted diseases, rising geriatric population are some of the key driving factors responsible for the growth of the market. Urinalysis tool is used for disease management and diagnosis. Furthermore, unmet clinical needs in the emerging nations and increasing target patient population are some other factors responsible for the urinalysis market growth. The development of advanced diagnostic tools has posed some growth opportunities for the market. Moreover, unhealthy dietary choices, sedentary lifestyle has propelled the proliferation of the market. On the other hand, a dearth of basic healthcare infrastructure in emerging countries is one of the key impediments over the market growth.

Urinalysis Market

Market Segmentation:

By Product
•   Consumables
•   Instruments
By Application
•   Urinary Tract Infection
•   Kidney Diseases
•   Diabetes
•   Liver Diseases
By End User
•   Clinical Laboratories
•   Hospitals
•   Research and Academic
•   Home Healthcare
By Region
•   North America
•   Europe
•   Asia-Pacific
•   Latin America
•   Middle East and Africa

The global market is fragmented into product, application, end user and region. The product segment is categorised into consumables and instruments. The instruments segment is bifurcated into semi-automated and automated biochemical urine analyzers, microscopic urine analyzers and urine sediment analyzers. The instruments segment is predicted to hold the largest urinalysis market share owing to advancements in technology like urine strip readers that are fully automated and automatic urine sediment analyzers like UriSed 2 and UriSed mini.
The application segment is fragmented into urinary tract infection, diabetes, hypertension, kidney diseases, and liver diseases. Urinalysis is issued for managing and treating appalling diseases like chronic kidney disease, urinary bladder cancer and diabetes. The urinary tract infection segment is anticipated to dominate the market during the forecast period owing to urinalysis providing effective diagnosis for urinary tract infection coupled with an increased number of patients diagnosed with hospital-acquired urinary tract infection. The end user segment is categorised into clinical laboratories, hospitals, research and academic and home healthcare. The clinical laboratories is anticipated to subjugate the market and this is due to increased volumes of procedures pertaining with these establishments. With automation being the current urinalysis market trend in the urine analysis diagnostics, it is anticipated to offer acceleration to the augmentation of the market.

Regional Analysis:

The North America region dominated the market owing to the presence of key market players, advanced healthcare infrastructure, increased disposable income and unhealthy dietary choices. The Asia pacific region, on the other hand, is anticipated to showcase substantial growth owing to a rising target population whose clinical requirements are not fulfilled, increased presence of local manufacturers.

Competitive Landscape:

Some of the key market players included are Seimens Healthineers, Roche Diagnostics, Cardinal Health, Arkray Inc., Sysmex Corporation, Alere Inc., Beckman Coulter, Bio-Rad Laboratories, 77 Elektronika Kft, DIRUI, ACON Laboratories, Quidel Corporation, URIT Medical Electronic Ltd.

FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis
• Key market trends
• Key data-points affecting market growth

Objectives of the Study:

• To provide with an exhaustive analysis on the global urinalysis market by product, application, end user and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
• To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

•   We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•   The customization Mobility Care offered are free of charge with purchase of any license of the report
•   You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com